HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced an oral presentation on ...
MIDDLETON, Wis.--(BUSINESS WIRE)--Spectrum Brands Holdings, Inc. (NYSE: SPB; “Spectrum Brands” or the “Company”), a leading global branded consumer products and home essentials company focused on ...
-- Commercial employee (non-executive) who was hired specifically for the launch of ROLVEDON™ (eflapegrastim-xnst) injection is the recipient of this grant -- The RSUs will vest over three years on ...
The first major result of Carr's license threat was that EchoStar last month agreed to sell $23 billion worth of spectrum licenses to AT&T. Today, EchoStar announced its $17 billion deal to sell its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback